Many of these ox-GPCs exhibit platelet-activating factor (PAF)-like agonistic activity and bind to a G-protein coupled, PAF-receptor (Ptafr; PAFR), expressed on a variety of cell types including tumor cells [29,30,31]. This evidence concerns the gene PCLAF and neoplasm.